ODM-201, a New Generation Androgen Receptor Inhibitor for Castration-Resistant Prostate Cancer: Preclinical and Phase I Data.
Journal of Clinical Oncology - United States
doi 10.1200/jco.2013.31.6_suppl.65
Full Text
Open PDFAbstract
Available in full text
Date
February 20, 2013
Authors
Publisher
American Society of Clinical Oncology (ASCO)